Top

BMC Infectious Diseases

Published in:

Open Access 01-12-2017 | Research article

Prevalence of congenital cytomegalovirus infection in symptomatic newborns under 3 weeks in Tehran, Iran

Authors: Mina Ebrahimi-Rad, Talayeh Seyed Shakeri, Fariba Shirvani, Kiana Shahrokhi, Nader Shahrokhi

Published in: BMC Infectious Diseases | Issue 1/2017

Abstract

Background

Cytomegalovirus (CMV) is a common cause of congenital infection worldwide and infants with symptomatic congenital CMV (cCMV) infection are at significantly increased risk of developing adverse long-term outcomes. This study aimed to determine the prevalence of cCMV infections in symptomatic infants under 3 weeks in Tehran, IRAN and to evaluate the usefulness of serologic markers in these neonates.

Methods

Urine and serum samples of 100 symptomatic infants, under 3 weeks old, with clinical signs referred to Tehran medical centers from June 2013 to December 2014, were collected and tested for CMV-DNA and IgG/IgM antibody titers by PCR and ELISA, respectively.

Results

CMV-DNA was detected in urine of 58 cases, whereas only 20 cases had detectable CMV-IgM titers. All CMV-IgM positive cases excreted CMV-DNA through their urine. Of the 100 patients, only 59 had CMV-IgG antibody and CMV-DNA was found in the urine of only 40 of them.

Conclusions

We conclude that CMV is an important etiologic agent of congenital infections in symptomatic infants in Tehran, IRAN (prevalence: 58%) and CMV-DNA detection immediately after delivery is recommended for early treatment and reduction of post infection problems. Furthermore, our study showed that the serologic markers are unreliable for diagnosis of cCMV infection in infants. This is the first report of cCMV prevalence in symptomatic congenital infections in Iran showing similarity with the world averages.

Davison AJ. Herpesvirus systematics. Vet Microbiol. 2010;143:52–69. doi:10.1016/j.vetmic.2010.02.014. CrossRefPubMedPubMedCentral

Yamamoto AY, Mussi-Pinhata MM, de Lima Isaac M, Amaral FR, Carvalheiro CG, Aragon DC, et al. Congenital cytomegalovirus infection as a cause of sensorineural hearing loss in a highly immune population. Pediatr Infect Dis J. 2011;30:1043–6. doi:10.1097/INF.0b013e31822d9640.

Marin LJ, Santos de Carvalho Cardoso E, Bispo Sousa SM, Debortoli de Carvalho L, Marques Filho MF, Raiol MR, et al. Prevalence and clinical aspects of CMV congenital infection in a low-income population. Virol J. 2016;13:148. doi:10.1186/s12985-016-0604-5. CrossRefPubMedPubMedCentral

Bello C, Whittle H. Cytomegalovirus infection in Gambian mothers and their babies. J Clin Pathol. 1991;44:366–9. doi:10.1136/jcp.44.5.366. CrossRefPubMedPubMedCentral

Zhang X-WW, Li F, Yu X-WW, Shi X-WW, Shi J, Zhang J-PP. Physical and intellectual development in children with asymptomatic congenital cytomegalovirus infection: a longitudinal cohort study in Qinba mountain area, China. J Clin Virol. 2007;40:180–5. doi:10.1016/j.jcv.2007.08.018.CrossRefPubMed

Fowler KB, Dahle AJ, Boppana SB, Pass RF. Newborn hearing screening: will children with hearing loss caused by congenital cytomegalovirus infection be missed? J Pediatr. 1999;135:60–4.CrossRefPubMed

Bissinger AL, Sinzger C, Kaiserling E, Jahn G. Human cytomegalovirus as a direct pathogen: correlation of multiorgan involvement and cell distribution with clinical and pathological findings in a case of congenital inclusion disease. J Med Virol. 2002;67:200–6. doi:10.1002/jmv.2208. CrossRefPubMed

McCarthy M, Auger D, Whittemore SR. Human cytomegalovirus causes productive infection and neuronal injury in differentiating fetal human central nervous system neuroepithelial precursor cells. J Hum Virol. 2000;3:215–28.PubMed

Misono S, Sie K, Weiss N, Huang M-L. Congenital cytomegalovirus infection in pediatric hearing loss. Arch Otolaryngol. Head Neck Surg. 2011;137:47–53. doi:10.1001/archoto.2010.235.Congenital.

10.

Stagno S, Pass RF, Dworsky ME, Alford CA. Congenital and perinatal cytomegalovirus infections. Semin Perinatol. 1983;7:31–42.PubMed

11.

Mussi‐Pinhata MM, Yamamoto AY, Brito RMM, de Lima Isaac M, de Carvalhoe Oliveira PF, Boppana S, et al. Birth prevalence and natural history of congenital cytomegalovirus infection in a highly Seroimmune population. Clin Infect Dis. 2009;49:522–8. doi:10.1086/600882.

12.

Yamamoto AY, Mussi-Pinhata MM, Marin LJ, Brito RM, Oliveira PFC, Coelho TB. Is saliva as reliable as urine for detection of cytomegalovirus DNA for neonatal screening of congenital CMV infection? J Clin Virol. 2006;36:228–30. 10.1016/j.jcv.2006.03.011. CrossRefPubMed

13.

Revello MG, Lilleri D, Zavattoni M, Middeldorp J, Gerna G, Furione M. Prenatal diagnosis of congenital human cytomegalovirus infection in amniotic fluid by nucleic acid sequence-based amplification assay prenatal diagnosis of congenital human cytomegalovirus infection in amniotic fluid by nucleic acid sequence-based Amplifi. J Clin Microbiol. 2003;41:1772–4. doi:10.1128/JCM.41.4.1772. CrossRefPubMedPubMedCentral

14.

Lazzarotto T, Brojanac S, Maine GT, Landini MP. Search for cytomegalovirus-specific immunoglobulin M: comparison between a new western blot, conventional western blot, and nine commercially available assays. Clin Diagn Lab Immunol. 1997;4:483–6.PubMedPubMedCentral

15.

Coll O, Benoist G, Ville Y, Weisman LE, Botet F, Anceschi M, et al. Guidelines on CMV congenital infection. J Perinat Med. 2009;37:433–45. doi:10.1515/JPM.2009.127. CrossRefPubMed

16.

Vauloup-Fellous C, Ducroux A, Couloigner V, Marlin S, Picone O, Galimand J, et al. Evaluation of cytomegalovirus (CMV) DNA quantification in dried blood spots: retrospective study of CMV congenital infection. J Clin Microbiol. 2007;45:3804–6. doi:10.1128/JCM.01654-07. CrossRefPubMedPubMedCentral

17.

Albanna EAE, El-latif RSA, Sharaf HA, Gohar MK, Ibrahim BM. Diagnosis of congenital cytomegalovirus infection in high risk neonates. Mediterr J Hematol Infect Dis. 2013;5:1–7. doi:10.4084/MJHID.2013.049. CrossRef

18.

Priya K, Madhavan HN. Diagnostic value of enzyme linked immuno-sorbent assay for cytomegalovirus disease. J Postgrad Med. 2002;48:176–8. discussion 190PubMed

19.

Bagheri L, Mokhtarian H, Sarshar N, Ghahramani M. Seroepidemiology of cytomegalovirus infection during pregnancy in Gonabad, eastern Iran: a cross-sectional study. J Res Health Sci. 2012;12:38–44.PubMed

20.

Monavari SH, Keyvani H, Kiasari BA, Mollaei H, Fazlalipour M, Vaziri MS, et al. Detection of cytomegalovirus ( CMV ) antibodies or DNA sequences from ostensibly healthy Iranian mothers and their neonates. Int J Med Med Sci. 2012;4:155–9. doi:10.5897/IJMMS11.138.

21.

Mostafavi SN, Ataei B, Nokhodian Z, Yaran M, Babak A, Salehi A, et al. Seroprevalence of cytomegalovirus infection and estimate of congenital cytomegalovirus infection in Isfahan state, Iran: a population based study. Pakistan J Med Sci. 2013;29:418–22. doi:10.12669/pjms.291(Suppl).3546.

22.

Journal I, Society I, Transfusion B, Medicine T. Original article Seroprevalence of cytomegalovirus infection in pregnant women referred to health Care Center of Khorramabad. Iran J Virol. 2011;5:11–6.

23.

Javid N, Cheraghali F, Moradi A, Kelishadi M, Tabarraei A. Newborn screening for congenital cytomegalovirus infection in Iran. Pediatr Infect Dis J. 2016;35:1052. doi:10.1097/INF.0000000000001257. CrossRefPubMed

24.

Hyde TB, Schmid DS, Cannon MJ. Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMV. Rev Med Virol. 2010;20:311–26. doi:10.1002/rmv.659. CrossRefPubMed

25.

Britt WJ. Cytomegalovirus. In: Wilson CB, Nizet V, Maldonado Y, Remington JS, Klein JO, editors. Remington and Klein’s infectious diseases of the fetus and newborn, 8th ed. Elsevier Health Sciences; 2016. p. 724–81.

26.

Lanzieri TM, Dollard SC, Bialek SR, Grosse SD. Systematic review of the birth prevalence of congenital cytomegalovirus infection in developing countries. Int J Infect Dis. 2014;22:44–8. doi:10.1016/j.ijid.2013.12.010. CrossRefPubMedPubMedCentral

27.

Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol. 2007;17:355–63. doi:10.1002/rmv.544.CrossRefPubMed

28.

Boppana SB, Ross SA, Shimamura M, Palmer AL, Ahmed A, Michaels MG, et al. Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns. N Engl J Med. 2011;364:2111–8. doi:10.1056/NEJMoa1006561. CrossRefPubMedPubMedCentral

29.

Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol. 2007;17:253–76. doi:10.1002/rmv.535. CrossRefPubMed

30.

Paixão P, Almeida S, Videira PA, Ligeiro D, Marques T. Screening of congenital cytomegalovirus infection by real-time PCR in urine pools. Eur J Pediatr. 2012;171:125–9. doi:10.1007/s00431-011-1496-4. CrossRefPubMed

31.

Nitsche A, Steuer N, Schmidt CA, Landt O, Ellerbrok H, Pauli G, et al. Detection of human cytomegalovirus DNA by real-time quantitative PCR. J Clin Microbiol. 2000;38:2734–7.PubMedPubMedCentral

32.

Bélec L, Brogan TV. Real-time PCR-based testing of saliva for cytomegalovirus at birth. Expert Rev Anti-Infect Ther. 2011;9:1119–24. doi:10.1586/eri.11.130. CrossRefPubMed

33.

Pillet S, Roblin X, Cornillon J, Mariat C, Pozzetto B. Quantification of cytomegalovirus viral load. Expert Rev Anti-Infect Ther. 2014;12:193–210. 10.1586/14787210.2014.870887. CrossRefPubMed

34.

Bobek V, Kolostova K, Pinterova D, Kacprzak G, Adamiak J, Kolodziej J, et al. A clinically relevant, syngeneic model of spontaneous, highly metastatic B16 mouse melanoma. Anticancer Res. 2010;30:4799–804. doi:10.1002/jmv. PubMed

35.

Yamaguchi A, Oh-ishi T, Arai T, Sakata H, Adachi N, Asanuma S, et al. Screening for seemingly healthy newborns with congenital cytomegalovirus infection by quantitative real-time polymerase chain reaction using newborn urine: an observational study. BMJ Open. 2017;7:e013810. doi:10.1136/bmjopen-2016-013810. CrossRefPubMedPubMedCentral

36.

Yamamoto AY, Mussi-Pinhata MM, Pinto PCG, Figueiredo LTM, Jorge SM. Usefulness of blood and urine samples collected on filter paper in detecting cytomegalovirus by the polymerase chain reaction technique. J Virol Methods. 2001;97:159–64. doi:10.1016/S0166-0934(01)00347-0. CrossRefPubMed

37.

Balcarek KB, Warren W, Smith RJ, Lyon MD, Pass RF. Neonatal screening for congenital cytomegalovirus infection by detection of virus in saliva. J Infect Dis. 1993;167:1433–6.CrossRefPubMed

38.

Miura C, Miura E, Mombach A, Chesky M. The prevalence of congenital cytomegalovirus infection in newborn infants at an intensive care unit in a public hospital. J Pediatr (Rio J). 2006;82:46–50.

39.

Kanda Y, Chiba S, Suzuki T, Kami M, Yazaki Y, Hirai H. Time course analysis of semi-quantitative PCR and antigenaemia assay for prevention of cytomegalovirus disease after bone marrow transplantation. Br J Haematol. 1998;100:222–5. doi:10.1046/j.1365-2141.1998.00518.x. CrossRefPubMed

40.

Boivin G, Handfield J, Toma E, Lalonde R, Bergeron MG. Expression of the late cytomegalovirus (CMV) pp150 transcript in leukocytes of AIDS patients is associated with a high viral DNA load in leukocytes and presence of CMV DNA in plasma. J Infect Dis. 1999;179:1101–7. doi:10.1086/314721. CrossRefPubMed

41.

Parmigiani SV, Barini R, Costa SCB, Amaral E, da Silva JCG, Pinto E Silva JLDC. Accuracy of the serological ELISA test compared with the polymerase chain reaction for the diagnosis of cytomegalovirus infection in pregnancy. Sao Paulo Med J. 2003;121:97–101.

42.

Noorbakhsh S, Farhadi M, Tabatabaei A. Cytomegalovirus, a Common Cause of Intrauterine Infection : A Case-Control Study in Tehran, Iran. Iran J Pediatr Soc. 2010;2:31–6.

43.

Bhatia J, Shah BV, Mehta AP, Deshmukh M, Sirsat RA, Rodrigues C. Comparing serology, antigenemia assay and polymerase chain reaction for the diagnosis of cytomegalovirus infection in renal transplant patients. J Assoc Physicians India. 2004;52:297–300.PubMed

44.

Naumnik B, Małyszko J, Chyczewski L, Kovalchuk O, Małyszko J, Myśliwiec M. Comparison of serology assays and polymerase chain reaction for the monitoring of active cytomegalovirus infection in renal transplant recipients. Transplant Proc. 2007;39:2748–50. doi:10.1016/j.transproceed.2007.08.040. CrossRefPubMed

45.

Rasmussen L, Kelsall D, Nelson R, Carney W, Hirsch M, Winston D, et al. Virus-specific IgG and IgM antibodies in normal and immunocompromised subjects infected with cytomegalovirus. J Infect Dis. 1982;145:191–9. doi:10.1093/infdis/145.2.191. CrossRefPubMed

46.

Fowler KB, Stagno S, Pass RF. Maternal age and congenital cytomegalovirus infection: screening of two diverse newborn populations, 1980–1990. J Infect Dis. 1993;168:552–6.CrossRefPubMed

47.

Boppana SB, Fowler KB, Britt WJ, Stagno S, Pass RF. Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus. Pediatrics. 1999;104:55–60.CrossRefPubMed

Title: Prevalence of congenital cytomegalovirus infection in symptomatic newborns under 3 weeks in Tehran, Iran
Authors: Mina Ebrahimi-Rad
Talayeh Seyed Shakeri
Fariba Shirvani
Kiana Shahrokhi
Nader Shahrokhi
Publication date: 01-12-2017
Publisher: BioMed Central
Published in: BMC Infectious Diseases / Issue 1/2017
Electronic ISSN: 1471-2334
DOI: https://doi.org/10.1186/s12879-017-2799-5

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Prevalence of congenital cytomegalovirus infection in symptomatic newborns under 3 weeks in Tehran, Iran

Abstract

Background

Methods

Results

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2017

Factors contributing to anaemia after uncomplicated falciparum malaria in under five year-old Nigerian children ten years following adoption of artemisinin-based combination therapies as first-line antimalarials

Recurrence of cystic echinococcosis in an endemic area: a retrospective study

Radiation used for head and neck cancer increases virulence in Candida tropicalis isolated from a cancer patient

Fusobacterial liver abscess: a case report and review of the literature

Prevalence and molecular characteristics of Staphylococcus aureus, including methicillin resistant strains, isolated from bulk can milk and raw milk products in pastoral communities of South-West Uganda

The first occurrence of a CTX-M ESBL-producing Escherichia coli outbreak mediated by mother to neonate transmission in an Irish neonatal intensive care unit

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page